Product Description:

Trenbolone Hexahydrobenzylcarbonate is a potent injectable anabolic steroid. Due to its hexahydrobenzylcarbonate ester, it shares almost the same pharmacokinetic properties with testosterone hexahydrobenzylcarbonate, with steroid levels peaking a few days after injection and then declining over about two weeks. The base steroid, Trenbolone, is a derivative of Nandrolone, possessing high anabolic and potent androgenic properties. Although it is an anabolic/androgenic steroid, per milligram, Trenbolone Hexahydrobenzylcarbonate is more effective than testosterone, promoting a better balance of anabolism in the body (pertaining to metabolism). It does not convert to estrogen but exhibits significant progestogenic activity, which may cause estrogenic side effects under certain conditions. Trenbolone Hexahydrobenzylcarbonate can essentially replace Trenbolone Cyclohexylmethylcarbonate, effectively enhancing lean muscle mass, and improving muscle hardness and definition.

Product History:

Trenbolone Hexahydrobenzylcarbonate was first developed in 1967 by Roussel-UCLAF as part of a series of anabolic steroid experiments. During the 1960s, while extensive use of Trenbolone was being explored, Trenbolone Hexahydrobenzylcarbonate was not specifically researched until decades later. It first hit the commercial market in 2004, introduced by the underground manufacturer British Dragon under the trade name Trenabol, containing 200mg/ml of Trenbolone Hexahydrobenzylcarbonate.

Although not sold in pharmacies nor approved for human or animal use, Trenbolone has been widely favored by athletes around the world. Trenbolone Hexahydrobenzylcarbonate remains one of the few injectable long-acting steroids available, dominating the Trenbolone product line to this day. Although British Dragon was perhaps the largest and most famous underground steroid manufacturer at the time, it suddenly went out of business in 2006. Since then, new brands of Trenbolone Hexahydrobenzylcarbonate have re-entered the market. Today, it continues to be produced by some underground manufacturers and circulates in the legal drug market without an official trademark.

Specifications Offered:

Trenbolone Hexahydrobenzylcarbonate is not available as a prescription drug.

Structural Characteristics:

Trenbolone is a modified form of Nandrolone. It differs by the introduction of double bonds at carbon atoms 9 and 11, which inhibit aromatization (9-ene), increase androgen receptor binding, and decrease its metabolism. This modification makes Trenbolone a more potent anabolic steroid than others and a more effective androgen than Nandrolone. Trenbolone is bound to the hexahydrobenzylcarbonate ester at the 17β-hydroxy group, allowing the free steroid to release slowly from the injection site.

Side Effects (Estrogenic):

Trenbolone Hexahydrobenzylcarbonate is not aromatizable by the body and shows no significant estrogenic activity. However, it exhibits notable affinity for progesterone receptors (slightly stronger than progesterone itself). Its progestogenic side effects are similar to those of estrogen, including negative feedback inhibition of testosterone production and increased rate of fat storage. Progestins also enhance the stimulatory effect of estrogens on mammary tissue growth. There appears to be a strong synergistic interaction between these hormones, so even individuals with low estrogen levels may develop gynecomastia under the influence of progestins. Taking anti-estrogens to suppress estrogen can alleviate these symptoms. Note that when Trenbolone is used with other aromatizable steroids, progestogenic side effects are more common.

Side Effects (Androgenic):

Although classified as an anabolic steroid, Trenbolone Hexahydrobenzylcarbonate has significant androgenic properties. Therefore, common side effects related to androgens may include oily skin, acne, and growth of body/facial hair. Anabolic/androgenic steroids can also exacerbate male pattern baldness. Female users should be aware that side effects might include deepening of the voice, menstrual irregularities, changes in skin texture, facial hair growth, and clitoral enlargement. As Trenbolone is not metabolized by 5-alpha reductase, it is not affected significantly by the use of finasteride or dutasteride.

Side Effects (Hepatotoxicity):

Since Trenbolone is not C-17α-alkylated, it is generally not considered hepatotoxic and is unlikely to exhibit liver toxicity. However, strong anti-metabolic resistance has been noted, and severe liver toxicity can occur in bodybuilders who abuse the drug. Thus, while it is generally not expected to have hepatotoxic effects, these cannot be completely excluded, especially at high doses.

Side Effects (Cardiovascular):

As an anabolic/androgenic steroid, Trenbolone Hexahydrobenzylcarbonate can adversely affect serum cholesterol. This includes a tendency to lower HDL (good) cholesterol values and increase LDL (bad) cholesterol values, potentially shifting the HDL to LDL balance in a way that increases the risk of arteriosclerosis. The impact of anabolic/androgenic steroids on serum lipids depends on the dose, the route of administration (oral or injectable), the type of steroid (aromatizable or non-aromatizable), and the level of resistance to hepatic metabolism. Trenbolone Hexahydrobenzylcarbonate's anti-hepatic metabolism and (oral) administration route significantly affect cholesterol levels in the liver. Anabolic/androgenic steroids can also adversely affect blood pressure and triglycerides, reduce endothelial relaxation, and promote left ventricular hypertrophy, all of which potentially increase the risk of cardiovascular disease and myocardial infarction.

To help reduce cardiovascular strain, it is advised to maintain an active cardiovascular exercise program and minimize the intake of saturated fats, cholesterol, and simple carbohydrates during active AAS administration. It is also recommended to supplement with fish oil (4 grams per day) and a natural cholesterol/antioxidant formula such as Lipid Stabil or a similar product.

Side Effects (Testosterone Suppression):

Sufficient doses of synthetic/androgenic steroids are expected to suppress endogenous testosterone production. Without intervention from testosterone-stimulating substances, testosterone levels should normalize within 1-4 months after cessation of drug use. Note that prolonged hypogonadotropic hypogonadism may develop secondary to steroid abuse, requiring medical intervention. Studies indicate that per milligram, Trenbolone's suppressive effect on gonadotropins is approximately three times that of testosterone.

Therapeutic Guidance (Male):

Trenbolone Hexahydrobenzylcarbonate has never been used for human therapy, so no prescription guidelines are available. For physical enhancement and performance improvement, the common dosage is 150-300 mg per week, administered for 6-10 weeks. This dosage is sufficient to significantly increase muscle mass and strength while decreasing body fat and enhancing muscle definition. Like other Trenbolone injections, Trenbolone Hexahydrobenzylcarbonate is quite flexible and can be combined with other products as needed.

Therapeutic Guidance (Female):

Trenbolone Hexahydrobenzylcarbonate has never been used for human therapy, so no prescription guidelines are provided. Due to its strong androgenic nature and the tendency to produce severe virilization effects, it is generally not recommended for female use for physical enhancement or performance improvement purposes.

Prev: Testosterone enanthate

Next: Testosterone

热门CYCLE

肽类循环-1

职业级减脂11

职业级减脂10

中级减脂-15

初级减脂-11

初级减脂-10